SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001469709-21-000077
Filing Date
2021-12-17
Accepted
2021-12-17 15:40:58
Documents
1
Effectiveness Date
2021-12-17
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 6122
  Complete submission text file 0001469709-21-000077.txt   7312
Mailing Address 425 MADISON AVENUE, SUITE 902 NEW YORK NY 10017
Business Address 425 MADISON AVENUE, SUITE 902 NEW YORK NY 10017 212-874-6608
AngioGenex, Inc. (Filer) CIK: 0001085596 (see all company filings)

IRS No.: 860945116 | State of Incorp.: NV | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-425689 | Film No.: 211501314
SIC: 2834 Pharmaceutical Preparations